{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:40:40Z","timestamp":1790527240833,"version":"4.1.0"},"reference-count":40,"publisher":"The Journal of Rheumatology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2023,12,3]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Soluble transferrin receptor (sTfR) is considered to be a useful biomarker for the diagnosis of iron deficiency, especially in the setting of inflammation, as it is thought to not be affected by inflammation. We analyzed the relationship between sTfR levels and inflammatory markers in patients with known or suspected inflammatory rheumatic disease (IRD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Blood samples of 1001 patients with known or suspected IRD referred to a tertiary rheumatology center were analyzed. Study participants were classified as patients with active IRD and patients with inactive IRD or without IRD. Correlation analyses were used to explore the relationship between sTfR levels and inflammatory markers (ie, C-reactive protein [CRP], erythrocyte sedimentation rate [ESR]). We applied multiple linear regression analysis to evaluate the predictive value of CRP levels for sTfR concentrations after adjustment for potential confounding factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were positive correlations between inflammatory markers (CRP, ESR) and serum sTfR levels (\u03c1 0.44, \u03c1 0.43, respectively;\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), exceeding the strength of correlation between inflammatory markers and the acute phase reactant ferritin (\u03c1 0.30, \u03c1 0.23, respectively;\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001). Patients with active IRD demonstrated higher serum sTfR levels compared to patients with inactive or without IRD (mean 3.99 [SD 1.69] mg\/L vs 3.31 [SD 1.57] mg\/L;\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001). After adjustment for potential confounding factors, CRP levels are predictive for serum sTfR concentrations (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study provides evidence against the concept that sTfR is a biomarker not affected by inflammation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.2023-0654","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T08:20:10Z","timestamp":1705306810000},"page":"291-296","source":"Crossref","is-referenced-by-count":7,"title":["Association of Serum Soluble Transferrin Receptor Concentration With Markers of Inflammation: Analysis of 1001 Patients From a Tertiary Rheumatology Center"],"prefix":"10.3899","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-1748","authenticated-orcid":false,"given":"Florian","family":"G\u00fcnther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1165-4555","authenticated-orcid":false,"given":"Rainer H.","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Ehrenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Schminke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"key":"2024031404501027000_51.3.291.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-06-856500"},{"key":"2024031404501027000_51.3.291.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202709"},{"key":"2024031404501027000_51.3.291.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.183"},{"key":"2024031404501027000_51.3.291.4","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s10067-019-04873-y","article-title":"Inflammatory anemia may be an indicator for predicting disease activity and structural damage in Chinese patients with rheumatoid arthritis","volume":"39","author":"Chen","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2024031404501027000_51.3.291.5","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1016\/j.amjmed.2003.12.012","article-title":"Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature","volume":"116","author":"Wilson","year":"2004","journal-title":"Am J Med"},{"key":"2024031404501027000_51.3.291.6","first-page":"560","article-title":"Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry","volume":"27","author":"Furst","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"2024031404501027000_51.3.291.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2007.05.007"},{"key":"2024031404501027000_51.3.291.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041809"},{"key":"2024031404501027000_51.3.291.9","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2011.117507"},{"key":"2024031404501027000_51.3.291.10","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeq361"},{"key":"2024031404501027000_51.3.291.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60865-0"},{"key":"2024031404501027000_51.3.291.12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/1529-0131(200104)44:4<979::AID-ANR157>3.0.CO;2-H","article-title":"Ferritin and serum transferrin receptor predict iron deficiency in anemic patients with rheumatoid arthritis","volume":"44","author":"Bultink","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2024031404501027000_51.3.291.13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V96.3.823","article-title":"Erythropoietin, iron, and erythropoiesis","volume":"96","author":"Goodnough","year":"2000","journal-title":"Blood"},{"key":"2024031404501027000_51.3.291.14","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-016-0505-7"},{"key":"2024031404501027000_51.3.291.15","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200005)43:5<1016::AID-ANR9>3.0.CO;2-3"},{"key":"2024031404501027000_51.3.291.16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.beem.2015.09.003","article-title":"Beyond soluble transferrin receptor: old challenges and new horizons","volume":"29","author":"Harms","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2024031404501027000_51.3.291.17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12311"},{"key":"2024031404501027000_51.3.291.18","doi-asserted-by":"publisher","DOI":"10.3109\/10408363.2010.550461"},{"key":"2024031404501027000_51.3.291.19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-195651"},{"key":"2024031404501027000_51.3.291.20","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21279"},{"key":"2024031404501027000_51.3.291.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(03)00005-6"},{"key":"2024031404501027000_51.3.291.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.02.034"},{"key":"2024031404501027000_51.3.291.23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.53.10.699"},{"key":"2024031404501027000_51.3.291.24","first-page":"445","article-title":"Serum erythropoietin and transferrin receptor levels in patients with rheumatoid arthritis","volume":"13","author":"No\u00e9","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"2024031404501027000_51.3.291.25","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.116.142232"},{"key":"2024031404501027000_51.3.291.26","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.116.142307"},{"key":"2024031404501027000_51.3.291.27","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.117.155937"},{"key":"2024031404501027000_51.3.291.28","doi-asserted-by":"crossref","first-page":"874846","DOI":"10.3389\/fcell.2022.874846","article-title":"Increased serum soluble transferrin receptor levels were associated with high prevalence of cardiovascular diseases: insights from the National Health and Nutrition Examination Survey 2017-2018","volume":"10","author":"Zhu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"2024031404501027000_51.3.291.29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/clinchem\/44.1.45","article-title":"Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations","volume":"44","author":"Mast","year":"1998","journal-title":"Clin Chem"},{"key":"2024031404501027000_51.3.291.30","doi-asserted-by":"crossref","first-page":"11911","DOI":"10.1038\/s41598-022-15674-w","article-title":"Soluble transferrin receptor can predict all-cause mortality regardless of anaemia and iron storage status","volume":"12","author":"Kang","year":"2022","journal-title":"Sci Rep"},{"key":"2024031404501027000_51.3.291.31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.6.2012"},{"key":"2024031404501027000_51.3.291.32","doi-asserted-by":"publisher","DOI":"10.1042\/bj2650621"},{"key":"2024031404501027000_51.3.291.33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.8.5047"},{"key":"2024031404501027000_51.3.291.34","doi-asserted-by":"publisher","DOI":"10.1002\/bies.950180909"},{"key":"2024031404501027000_51.3.291.35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.9.5375"},{"key":"2024031404501027000_51.3.291.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.08.002"},{"key":"2024031404501027000_51.3.291.37","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3390\/cells10092340","article-title":"Regulation of the hypoxia-inducible factor (HIF) by pro-inflammatory cytokines","volume":"10","author":"Malkov","year":"2021","journal-title":"Cells"},{"key":"2024031404501027000_51.3.291.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2016.11.003"},{"key":"2024031404501027000_51.3.291.39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.34.24142"},{"key":"2024031404501027000_51.3.291.40","doi-asserted-by":"publisher","DOI":"10.3945\/jn.112.167775"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2023-0654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T07:51:04Z","timestamp":1710402664000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2023-0654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,1]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.3899\/jrheum.2023-0654"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2023-0654","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,15]]}}}